Published in

Newlands Press, Future Medicinal Chemistry, 12(14), p. 899-913, 2022

DOI: 10.4155/fmc-2022-0006

Links

Tools

Export citation

Search in Google Scholar

Super-conserved receptors expressed in the brain: biology and medicinal chemistry efforts

Journal article published in 2022 by Alp Bayrak ORCID, Julien Hanson ORCID, Stefan Laufer ORCID, Thanigaimalai Pillaiyar ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

The super-conserved receptors expressed in the brain (SREB) constitute a family of orphan G protein-coupled receptors that include GPR27 (SREB1), GPR85 (SREB2) and GPR173 (SREB3). Their sequences are highly conserved in vertebrates, and they are almost exclusively expressed in the central nervous system. This family of receptors has attracted much attention due to their putative physiological functions and their potential as novel drug targets. The SREB family has been postulated to play important roles in a wide range of different diseases, including pancreatic β-cell insulin secretion and regulation, schizophrenia, autism and atherosclerosis. This review intends to provide a comprehensive overview of the SREB family and its recent advances in biology and medicinal chemistry.